SAFE
The diagnostic image-reading layer — fundus photos for diabetic retinopathy, OCT for macular degeneration, visual field interpretation — is where AI is already FDA-cleared and genuinely good, and that will compress screening volume and referral triage. But the revenue core is microsurgery: phacoemulsification, intravitreal injections, laser capsulotomy, retinal detachment repair, performed on a moving, anesthetized human eye with sub-millimeter tolerances no current robot handles autonomously. State licensure plus personal malpractice exposure means a physician signs every surgical plan and every off-label injection decision.
Tasks largely resist digitisation. Cataract extraction, anti-VEGF injections into the vitreous, YAG capsulotomy, trabeculectomy and scleral buckling are the daily schedule for most comprehensive ophthalmologists — and while the slit-lamp exam grading and OCT/fundus interpretation feeding those decisions is genuinely being automated, that displaced reading layer is a real fraction of clinic time, which is why this sits at 14 and not 18 like a purely operative specialty.
Hands-on in uncontrolled environments. You work with a hand on a joystick-mounted phaco handpiece inside a 12mm globe, tilt patients under an operating microscope, perform scleral depression and indirect ophthalmoscopy on uncooperative or photophobic patients, and manage intraoperative bleeding or capsule rupture in real time; it stops short of 20 only because a meaningful share of the week is clinic-based refraction, imaging review, and dictation at a desk.
Licensed human required and personally liable. State medical licensure, ABO board certification, ASC and hospital credentialing, and DEA registration for controlled post-op analgesia all gate the work, and the operative note plus the informed-consent discussion for endophthalmitis and retinal-detachment risk carry your name — a wrong-IOL-power implant or a missed giant cell arteritis is your malpractice claim, not the technician's who took the biometry.
The human relationship is the product. Patients agreeing to have someone open their only good eye, or to return every four weeks for years of intravitreal injections, are choosing a specific surgeon; but a large volume of cataract work still arrives through optometrist referral pipelines and Medicare-driven ASC scheduling where the patient meets you twice, which caps this below the 19-20 range of a concierge practice.
Exists to be accountable for ambiguous calls. Deciding whether a macula-off detachment goes to the OR tonight, whether to continue aflibercept in a non-responder or switch off-label, when to stop tapering steroids in uveitis with rising IOP, and whether a monocular patient's cataract density justifies surgical risk at all — these are calls made on incomplete evidence with irreversible outcomes, though many high-volume days follow well-established post-op and glaucoma-monitoring protocols.
Has AI actually changed your work?